Tempest Therapeutics Inc.
TPST | NASDAQ
$0.81
+$0.04 (+4.68%)
Sep 22, 2026, 12:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.45 | -7.23 | -29.95 | -4.70 | -8.80 | -0.68 |
PEG Ratio | 0 | 0.34 | 0.75 | 0.08 | 0.09 | 0 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.79 | 15.83 | 32.94 | 0.73 | 0.55 | -0.19 |
P/FCF Ratio | -0.44 | -9.05 | -32.03 | -0.42 | -0.77 | -0.68 |
P/OCF Ratio | -0.44 | -9.17 | -32.23 | -0.43 | -0.77 | -0.68 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 1.22 | 0.80 | 0.77 | 1.22 | 0.51 | -0.04 |
Quick Ratio | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 | 6.15 |
Current Ratio | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 | 6.15 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -128.38 | -31.93 | -20.12 | -21.41 | -21.05 | n/a |
Return on Equity | -393.85% | -218.78% | -110.17% | -197.17% | -78.36% | 27.79% |
Return on Assets | -155.11% | -100.86% | -57.15% | -77.48% | -38.64% | -83.62% |
Return on Invested Capital | -179.45% | -121.85% | -61.48% | -86.12% | -49.38% | -94.82% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TPST